KDP

What You May Have Missed About Keurig Dr Pepper (KDP)

A strong performer from today's afternoon trading session is Keurig Dr Pepper, whose shares rose 1.9% to $32.17 per share. For those of you thinking about investing in the stock, here is a brief value analysis of the stock using the company's basic fundamental ratios.

None:

Keurig Dr Pepper Inc. operates as a beverage company in the United States and internationally. The company belongs to the Consumer Staples sector, which has an average price to earnings (P/E) ratio of None and an average price to book (P/B) ratio of None. In contrast, Keurig Dr Pepper has a trailing 12 month P/E ratio of 23.5 and a P/B ratio of 1.77.

Keurig Dr Pepper's PEG ratio is 2.53, which shows that the stock is probably overvalued in terms of its estimated growth. For reference, a PEG ratio near or below 1 is a potential signal that a company is undervalued.

None:

Year 2018 2019 2020 2021 \ Revenue (MM) $7,442 $11,120 $11,618 $12,683
Gross Margins 52% 56% 56% 55%
Operating Margins 17% 21% 21% 23%
Net Margins 8% 11% 11% 17%
Net Income (MM) $589 $1,254 $1,325 $2,146
Net Interest Expense (MM) $401 $654 $604 $2
Depreciation & Amort. (MM) $nan $358 $362 $410
Earnings Per Share $0.53 $0.88 $0.93 $1.5
Diluted Shares (MM) 1,098 1,419 1,422 1,428

Year 2022 2023
Revenue (MM) $14,057 $14,750
Gross Margins 52% 54%
Operating Margins 19% 20%
Net Margins 10% 13%
Net Income (MM) $1,436 $1,941
Net Interest Expense (MM) $693 $693
Depreciation & Amort. (MM) $399 $397
Earnings Per Share $1.01 $1.38
Diluted Shares (MM) 1,428 1,375

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS